Content about Product Release

PARSIPPANY, N.J. —GlaxoSmithKline in April announced the launch of its new Nicorette Mini Lozenge, a smaller smoking cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market. The lozenges will be line-priced with existing smoking cessation products and will be sold as three small vials each containing 27 lozenges.

PARSIPPANY, N.J. GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking-cessation lozenge that dissolves three times faster than stop-smoking lozenges currently on the market. The lozenges will be lined-priced with existing smoking-cessation products and will be sold at U.S. retail healthcare centers as three small vials, each containing 27 lozenges.

NEW YORK The business of blood glucose meters has always been a business of “what will they think of next?” When people with diabetes didn’t aggressively test because of the painful, daily pin pricks of their fingertips, manufacturers secured approval for alternate site testing. Manufacturers also developed no-coding meters to eliminate any errors in testing that may have resulted from miscoded testing strips, when that was identified as a potential interface issue.